Comprehensive Guide to Substance Use Disorder and Treatment Strategies Practice Test

The main idea is to add a safety feature that reduces misuse by injection without compromising treatment when used as intended. Naloxone in these products has poor sublingual or oral bioavailability, so taken as prescribed, it doesn’t block buprenorphine or cause withdrawal, and the patient still gets the therapeutic relief from buprenorphine. If someone tries to inject the medication, naloxone becomes active systemically and can precipitate withdrawal, making the experience unpleasant and discouraging misuse and diversion. This combination therefore preserves the benefits of buprenorphine for opioid use disorder while reducing the incentive to misuse the product via injection.